Table 1

Description of the study sample in terms of categorical data, and assessments of association of chlamydia diagnosis with the other variables presented

Categorical dataCount [n, (% of n)]Number infected (% of row count)SignificanceOR (95% CI)
Chlamydia (n=115)
 Positive60 (52%)
 Negative55 (48%)
Gender (n=115)
 Male*96 (83%)49 (51%)p=0.581
 Female19 (17%)11 (58%)1.14 (0.74–1.75)
Ethnicity (n=107)
 White Caucasian*93 (86%)46 (50%)p=0.591
 Other14 (14%)8 (57%)1.15 (0.70–1.89)
Sexual orientation (n=109)
 Heterosexual104 (95%)55 (53%)p=0.671.32 (0.45–3.93)
 MSM/WSW*5 (5%)2 (40%)1
Symptoms (n=113)
 Yes28 (25%)17 (61%)p=0.301.28 (0.90–1.85)
 No*85 (75%)42 (49%)1
SI with infected partner (n=112)
 Once*22 (20%)7 (32%)p=0.031
 More than once90 (80%)53 (59%)1.79 (0.95–3.39)
Antibiotic use within the last 3 months (n=115)
 Yes*20 (17%)13 (65%)p=0.211
 No95 (83%)47 (50%)1.32 (0.90–1.92)
Previous history of chlamydia (n=114)
 Yes*28 (25%)10 (36%)p=0.051
 No86 (75%)49 (57%)1.60 (0.94–2.71)
History of other STIs (n=114)
 Yes*5 (5%)2 (40%)p=0.661
 No109 (95%)58 (53%)1.33 (0.45–3.95)
History of serious illness (n=115)
 Yes*5 (4%)1 (20%)p=0.201
 No110 (96%)59 (54%)2.68 (0.46–15.61)
Consistent condom use (n=115)
 Yes*17 (15%)7(41%)p=0.331
 No98 (85%)53 (54%)1.31 (0.72–2.38)
Contraception (n=115)
 Condoms95 (83%)51(53.7%)
 Hormonal16 (84%)§11 (69%)
 IUD/IUS1 (5%)§0
 None13 (11%)5 (39%)
  • * Reference category.

  • Fisher's exact test.

  • Some individuals used more than one method of contraception.

  • § As a percentage of the female cohort.

  • IUD, intrauterine device; IUS, intrauterine system; MSM, men who have sex with men; OR, odds ratio; SI, sexual intercourse; STI, sexually transmitted infection; WSW, women who have sex with women.